PARADIGM ASSET MANAGEMENT CO LLC - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARADIGM ASSET MANAGEMENT CO LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2015$411,086,000
-9.5%
16,3000.0%0.05%
-8.0%
Q1 2015$454,281,000
-67.6%
16,300
-78.8%
0.05%
-72.5%
Q4 2014$1,403,425,00076,9000.18%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders